Reichardt P, Bollmann A, Hohenstein S, et al. The Society for Surgery of the Alimentary Tract. Our results may assure the ability to maintain high quality of surgical care even in times of disruptions to the health care system.Īcute cholecystitis COVID-19 Emergency surgery Laparoscopic cholecystectomy Morbidity and mortality. Laparoscopic cholecystectomy has been safely applied during the pandemic. The numerous restrictions during the COVID-19 pandemic did not result in an increase of admissions or surgery for acute cholecystitis. Median length of stay was 4 days throughout all periods. Mortality was generally low (1.5-1.9%) with no differences between periods. We did not observe an increase in open surgery (proportion of open cholecystectomies 3.4-5.5%). Cholecystostomy was rare throughout all periods (0-0.5% of all patients). Proportion of patients with non-surgical treatment was low and not increased (11.7-17.3% vs. We could not demonstrate differences in daily admissions over the course of the pandemic (11.2-12.7 patients vs. In addition, we analyzed the type of treatment (non-surgical, cholecystostomy, or cholecystectomy) for all cases with main diagnosis of acute cholecystitis. Distribution of cases, type of surgery, comorbidities, surgical outcome, and length of stay of all cases with acute cholecystitis and cholecystectomy were compared. All in-patients with acute cholecystitis were included. Study periods were defined from Ma(start of first wave) to J(end of third wave) and compared to corresponding control periods (March 2018 to February 2020). Retrospective analysis of claims data from 74 German hospitals. To determine effects on admission, treatment, and outcome for acute cholecystitis during the course of the COVID-19 pandemic in 20.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |